Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer
Abstract Introduction Cisplatin-based chemotherapy is one of the fundamental therapeutic modalities for gastric cancer (GC). Chemoresistance to cisplatin is a great clinical challenge, and its underlying mechanisms remain poorly understood. Circular RNAs (circRNAs) are involved in the pathophysiolog...
Päätekijät: | , , , , , , , , , |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
BMC
2024-08-01
|
Sarja: | Journal of Nanobiotechnology |
Aiheet: | |
Linkit: | https://doi.org/10.1186/s12951-024-02760-6 |